Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
asparaginase erwinia chrysanthemi recombinant
MeSH Supplementary Concept Data 2025
Details
Concepts
MeSH Supplementary
asparaginase erwinia chrysanthemi recombinant
Unique ID
C000718243
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000718243
Entry Term(s)
asparaginase erwinia chrysanthemi, recombinant-rywn
rylaze
Pharm Action
Antineoplastic Agents
Registry Numbers
0
Related Numbers
D733ET3F9O
Heading Mapped to
*Amidohydrolases
Frequency
0
Note
To treat acute lymphoblastic leukemia and lymphoblastic lymphoma in patients who are allergic to E. coli-derived asparaginase products, as a component of a chemotherapy regimen
Date of Entry
2021/07/20
Revision Date
2024/03/15
Expand All
Collapse All
asparaginase erwinia chrysanthemi recombinant
Preferred
Concept UI
M000750563
Registry Numbers
0
Related Numbers
D733ET3F9O
Terms
asparaginase erwinia chrysanthemi recombinant
Preferred Term
Term UI
T001108962
Date
07/20/2021
LexicalTag
NON
ThesaurusID
NLM (2021)
rylaze
Narrower
Concept UI
M000750564
Terms
rylaze
Preferred Term
Term UI
T001108963
Date
07/20/2021
LexicalTag
TRD
ThesaurusID
NLM (2021)
asparaginase erwinia chrysanthemi, recombinant-rywn
Narrower
Concept UI
M000767497
Terms
asparaginase erwinia chrysanthemi, recombinant-rywn
Preferred Term
Term UI
T001108961
Date
07/20/2021
LexicalTag
NON
ThesaurusID
NLM (2021)
page delivered in 0.005s